These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 15024551)

  • 21. Fluorinated benzamide neuroleptics--III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2, 3-dimethoxybenzamide as an improved dopamine D-2 receptor tracer.
    Mukherjee J; Yang ZY; Das MK; Brown T
    Nucl Med Biol; 1995 Apr; 22(3):283-96. PubMed ID: 7627142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride.
    Narendran R; Frankle WG; Mason NS; Rabiner EA; Gunn RN; Searle GE; Vora S; Litschge M; Kendro S; Cooper TB; Mathis CA; Laruelle M
    Synapse; 2009 Jun; 63(6):447-61. PubMed ID: 19217025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Striatal and extrastriatal dopamine D2/D3 receptors in schizophrenia evaluated with [18F]fallypride positron emission tomography.
    Kegeles LS; Slifstein M; Xu X; Urban N; Thompson JL; Moadel T; Harkavy-Friedman JM; Gil R; Laruelle M; Abi-Dargham A
    Biol Psychiatry; 2010 Oct; 68(7):634-41. PubMed ID: 20673873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of isoflurane anesthesia on D2 receptor occupancy by [18F]fallypride measured by microPET with a modified Logan plot.
    Tantawy MN; Peterson TE; Jones CK; Johnson K; Rook JM; Conn PJ; Baldwin RM; Ansari MS; Kessler RM
    Synapse; 2011 Nov; 65(11):1173-80. PubMed ID: 21584868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spinal cord dopamine D2/D3 receptors: in vivo and ex vivo imaging in the rat using (18)F/(11)C-fallypride.
    Kaur J; Khararjian A; Coleman RA; Constantinescu CC; Pan ML; Mukherjee J
    Nucl Med Biol; 2014; 41(10):841-7. PubMed ID: 25199843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain and plasma pharmacokinetics of aripiprazole in patients with schizophrenia: an [18F]fallypride PET study.
    Gründer G; Fellows C; Janouschek H; Veselinovic T; Boy C; Bröcheler A; Kirschbaum KM; Hellmann S; Spreckelmeyer KM; Hiemke C; Rösch F; Schaefer WM; Vernaleken I
    Am J Psychiatry; 2008 Aug; 165(8):988-95. PubMed ID: 18381901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Striatal and extrastriatal dopamine D₂ receptor occupancy by the partial agonist antipsychotic drug aripiprazole in the human brain: a positron emission tomography study with [¹¹C]raclopride and [¹¹C]FLB457.
    Takahata K; Ito H; Takano H; Arakawa R; Fujiwara H; Kimura Y; Kodaka F; Sasaki T; Nogami T; Suzuki M; Nagashima T; Shimada H; Kato M; Mimura M; Suhara T
    Psychopharmacology (Berl); 2012 Jul; 222(1):165-72. PubMed ID: 22237854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitation of striatal and extrastriatal D-2 dopamine receptors using PET imaging of [(18)F]fallypride in nonhuman primates.
    Christian BT; Narayanan TK; Shi B; Mukherjee J
    Synapse; 2000 Oct; 38(1):71-9. PubMed ID: 10941142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 11C-Fallypride: radiosynthesis and preliminary evaluation of a novel dopamine D2/D3 receptor PET radiotracer in non-human primate brain.
    Mukherjee J; Shi B; Christian BT; Chattopadhyay S; Narayanan TK
    Bioorg Med Chem; 2004 Jan; 12(1):95-102. PubMed ID: 14697774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The interrelationship of dopamine D2-like receptor availability in striatal and extrastriatal brain regions in healthy humans: a principal component analysis of [18F]fallypride binding.
    Zald DH; Woodward ND; Cowan RL; Riccardi P; Ansari MS; Baldwin RM; Cowan RL; Smith CE; Hakyemez H; Li R; Kessler RM
    Neuroimage; 2010 May; 51(1):53-62. PubMed ID: 20149883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased dopamine D2/D3-receptor binding in temporal lobe epilepsy: an [18F]fallypride PET study.
    Werhahn KJ; Landvogt C; Klimpe S; Buchholz HG; Yakushev I; Siessmeier T; Müller-Forell W; Piel M; Rösch F; Glaser M; Schreckenberger M; Bartenstein P
    Epilepsia; 2006 Aug; 47(8):1392-6. PubMed ID: 16922886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [
    Stark AJ; Smith CT; Petersen KJ; Trujillo P; van Wouwe NC; Donahue MJ; Kessler RM; Deutch AY; Zald DH; Claassen DO
    Neuroimage Clin; 2018; 18():433-442. PubMed ID: 29541577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantification of dopamine D(2/3) receptors in rat brain using factor analysis corrected [18F]Fallypride images.
    Millet P; Moulin-Sallanon M; Tournier BB; Dumas N; Charnay Y; Ibáñez V; Ginovart N
    Neuroimage; 2012 Sep; 62(3):1455-68. PubMed ID: 22659483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differentiation of extrastriatal dopamine D2 receptor density and affinity in the human brain using PET.
    Olsson H; Halldin C; Farde L
    Neuroimage; 2004 Jun; 22(2):794-803. PubMed ID: 15193608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of d-amphetamine effects on the binding of dopamine D-2 receptor radioligand, 18F-fallypride in nonhuman primates using positron emission tomography.
    Mukherjee J; Yang ZY; Lew R; Brown T; Kronmal S; Cooper MD; Seiden LS
    Synapse; 1997 Sep; 27(1):1-13. PubMed ID: 9268060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positron emission tomography (PET) imaging of nicotine-induced dopamine release in squirrel monkeys using [
    Naylor JE; Hiranita T; Matazel KS; Zhang X; Paule MG; Goodwin AK
    Drug Alcohol Depend; 2017 Oct; 179():254-259. PubMed ID: 28818716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship between excitement symptom severity and extrastriatal dopamine D
    Joo YH; Kim JH; Son YD; Kim HK; Shin YJ; Lee SY; Kim JH
    Eur Arch Psychiatry Clin Neurosci; 2018 Sep; 268(6):529-540. PubMed ID: 28623450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced D2/D3 Receptor Binding of Extrastriatal and Striatal Regions in Temporal Lobe Epilepsy.
    Bernedo Paredes VE; Buchholz HG; Gartenschläger M; Breimhorst M; Schreckenberger M; Werhahn KJ
    PLoS One; 2015; 10(11):e0141098. PubMed ID: 26544593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PET measurement of changes in D2/D3 dopamine receptor binding in a nonhuman primate during chronic deep brain stimulation of the bed nucleus of the stria terminalis.
    Vandehey NT; Garell PC; Hampel JA; Murali D; Smith EM; Davidson R; Converse AK; Nickles RJ; Christian BT
    J Neurosci Methods; 2009 Jan; 176(2):129-35. PubMed ID: 18824196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia.
    Gründer G; Landvogt C; Vernaleken I; Buchholz HG; Ondracek J; Siessmeier T; Härtter S; Schreckenberger M; Stoeter P; Hiemke C; Rösch F; Wong DF; Bartenstein P
    Neuropsychopharmacology; 2006 May; 31(5):1027-35. PubMed ID: 16237387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.